Gas Chromatography -2 OVI

Embed Size (px)

Citation preview

  • 7/27/2019 Gas Chromatography -2 OVI

    1/32

    7/24/2013 UNICHEM 1

    Residual solvents

    New USP General Chapter

    Session II

    Mr. Shantanu Chobhe

    DGM-Analytical Services

    Unichem Laboratories Ltd., Mumbai

  • 7/27/2019 Gas Chromatography -2 OVI

    2/32

    7/24/2013 UNICHEM 2

    Introduction

    ..residual solvents in pharmaceuticals aredefined as organic volatile chemicals that areused or produced in the manufacture of drugsubstances or excipients, or in the preparation ofdrug products.

    ICH, USP, EP

    [Note: residual solvents refers to the amount notremoved during the purification of the product]

  • 7/27/2019 Gas Chromatography -2 OVI

    3/32

    7/24/2013 UNICHEM 3

    Introduction

    Residual solvents are one of the three maintypes of impurities in pharmaceutical articles,the other two being organic and inorganicimpurities.

    Therefore, Various Pharmacopeiasfrequentlyinclude a test for residual solvents, together withprocedures for the test and acceptance criteria.

  • 7/27/2019 Gas Chromatography -2 OVI

    4/32

    7/24/2013 UNICHEM 4

    Introduction

    The implementation of modern standards tocontrol these types of impurities has occupiedregulatory agencies, pharmaceuticalmanufacturers, and pharmacopeias for many

    years.

    Substantial progress in the overall effort camewith development of the ICH Q3C Guideline in

    1997 (Impurities: Guideline for Residual Solvents)and subsequent adoption of this Guideline as aFDA guidance.

  • 7/27/2019 Gas Chromatography -2 OVI

    5/32

    7/24/2013 UNICHEM 5

    History

    Chapter of USP was Organic VolatileImpurities(OVI)

    Individual monographs specify which method tofollow.

    OVIs controlled: Chloroform (60 ppm), Dioxane (380ppm), Methylene Chloride (600 ppm) and

    Trichloroethylene (80 ppm) Four methods: I, IV, V, and VI

    Standards: reagent grade solvents

    Direct injection or Headspace (Method IV) Column: G27 (Method I), G43 (Methods IV and V),

    various supports and coatings (Method VI)

    Dissolving solvent: water or the solvent specified in the

    monograph

  • 7/27/2019 Gas Chromatography -2 OVI

    6/32

    7/24/2013 UNICHEM 6

    HistoryICH Q3C and EP

    ICH Q3C Published in July 1997

    Revised in 2002

    EP adopts the ICH Q3C guideline in 1999.

    General Chapter 5.4. An introductory paragraphand reproduces the ICH Guideline

    Chapter 2.4.24 Identification and control of residualsolvents (Test methods for Class 1, 2 and 3Residual Solvents)

  • 7/27/2019 Gas Chromatography -2 OVI

    7/32

    7/24/2013 UNICHEM 7

    History

    USP incorporates ICH Q3Cclassificationand evaluation system and EPprocedures.

    USP was not consistent with ICH Q3CImpurity guideline (1997)

  • 7/27/2019 Gas Chromatography -2 OVI

    8/32

    7/24/2013 UNICHEM 8

    Revision of USP GeneralChapter

    First proposal to amend General Chapter and General Notices published in PF 29(4), 2003.

    Changes made effective (Mandatory) from 1st

    July 2008.

  • 7/27/2019 Gas Chromatography -2 OVI

    9/32

    7/24/2013 UNICHEM 9

    Changes Done

    The requirements have been aligned with the ICHguideline.

    The title changed from

    Organic volatile Impuritiesto

    Residual Solvents.All drug substances, excipients, and products are

    subject to relevant control of residual solvents,

    even when no test is specified in the individualmonograph.

    If solvents are used during production, they are of

    suitable quality.

  • 7/27/2019 Gas Chromatography -2 OVI

    10/32

    7/24/2013 UNICHEM 10

    Contd.. Changes Done

    The toxicity and residual level of each solvent are

    taken into consideration.

    The solvents are limited according to the

    principles defined and the requirements specified

    in Residual solvents, using the general

    methods presented therein or use of othersuitable methods.

  • 7/27/2019 Gas Chromatography -2 OVI

    11/32

    7/24/2013 UNICHEM 11

    Revised :Main Points

    1. Testing is to be performed only for solventslikely to be present

    used or produced in the final manufacturingstep

    used in previous steps and not removed bya validated procedure.

    2. The limits for acceptable concentrations listedin the Chapter are for drug products,not forits components.

  • 7/27/2019 Gas Chromatography -2 OVI

    12/32

    7/24/2013 UNICHEM 12

    Contd.. Revised :Main Points

    4. The concentration in the drug product may be

    calculated from the contributions ofcomponents

    determined experimentally; mandatory if

    solvents are used in its manufacture cumulative calculation exceeds limits

    5. Manufacturers of drug products may rely ondata provided by the suppliers of components

    6. Provides unambiguous identification andquantification methods

  • 7/27/2019 Gas Chromatography -2 OVI

    13/32

    7/24/2013 UNICHEM 13

    Contd.. Revised :Main Points

    7. Includes options to allow use of materials thatexceed the limits established.

    8. The procedures described in this general

    chapter are to be applied wherever possible.Otherwise, manufacturers may select the mostappropriate validated analytical procedure fora particular application.

  • 7/27/2019 Gas Chromatography -2 OVI

    14/32

    7/24/2013 UNICHEM 14

    Risk Based classification of Solvents

    Class 1 solvents: Solvents to be avoided

    Known human carcinogens, strongly suspectedhuman carcinogens, and environmental hazards.

    Class 2 solvents: Solvents to be limitedNon-genotoxic animal carcinogen or possiblecausative agents of others irreversible toxicitysuch as neurotoxicity or teratogenicity.

    Class 3 solvents: Solvents with low toxic

    potentialSolvents with low toxic potential to humanbeings.

    f

  • 7/27/2019 Gas Chromatography -2 OVI

    15/32

    7/24/2013 UNICHEM 15

    Limits of Residual Solvents Class 1:concentration limits, in ppm, are provided in a

    Table. They should not be exceeded unless otherwise

    stated in the individual monograph.

    Class 2:concentration limits are to be calculated fromPDE with the formula:

    Concentration (ppm) = 1000 PDE/dose, where PDE is

    in mg/day and dose is in g/day.A table is provided, to be used when the daily dose is10 g or less, or when the daily dose is not known orfixed.

    Class 3:PDE is 50 mg/day (unless otherwise stated inthe individual monograph.), corresponding to aconcentration of 0.5% for daily doses of 10 g or less.

  • 7/27/2019 Gas Chromatography -2 OVI

    16/32

    7/24/2013 UNICHEM 16

    Limits of Residual Solvents: Class 1

    Class 1 Residual Solvents (Table 1): Shouldnot be used in the manufacturing of drugsubstances, excipients or drug productsbecause of unacceptable toxicities or

    deleterious environmental effects of theresidual solvents.

    However if their use is unavoidable, theirlevels should be restricted as shown in

    Table 1.

  • 7/27/2019 Gas Chromatography -2 OVI

    17/32

    7/24/2013 UNICHEM 17

    Table 1. Class 1 Residual Solvents

    Solvent Limit

    (ppm)

    Concern

    Benzene 2 Carcinogen

    Carbon tetrachloride 4 Toxic andenvironmental Hazard

    1,2-Dichloroethane 5 Toxic

    1,1-Dichloroethene 8 Toxic

    1,1,1-Trichloroethane 1500 Environmental Hazard

  • 7/27/2019 Gas Chromatography -2 OVI

    18/32

    7/24/2013 UNICHEM 18

    Limits of Residual Solvents: Class 2

    Class 2: 27 solvents

    Class 2 Residual Solvents: should be limited indrug substances, excipients, and drugproducts because of their inherent toxicities.

    Their levels should be restricted as shown in

    Table 2. Concentration limits (ppm) varybetween 50 (methylbutylketone) and 3880(cyclohexane).

    When Class 2 residual solvents are used (or

    produced) in the manufacturing or purificationprocess, they should be identified andquantified

  • 7/27/2019 Gas Chromatography -2 OVI

    19/32

    7/24/2013 UNICHEM 19

    Table 2. Class 2 Residual Solvents

    SolventPDE

    (mg/day)Limit (ppm)

    Acetonitrile 4.1 410

    Chlorobenzene 3.6 360

    Chloroform 0.6 60

    Cyclohexane 38.8 3880

    1,2-Dichloroethene 18.7 1870

    1,2-Dimethoxyethane

    1.0 100

    N,N-Dimethylacetamide

    10.9 1090

    N,N-Dimethylformamide

    8.8 880

    1,4-Dioxane 3.8 380

    2-Ethoxyethanol 1.6 160

    Ethylene glycol 6.2 620

    Formamide 2.2 220

    Hexane 2.9 290

    Methanol 30.0 3000

    SolventPDE

    (mg/day)Limit (ppm)

    2-Methoxyethanol 0.5 50

    Methylbutylketone 0.5 50

    Methylcyclohexane 11.8 1180

    Methylene chloride 6.0 600

    N-Methylpyrrolidone 5.3 530

    Nitromethane 0.5 50

    Pyridine 2.0 200

    Sulfolane 1.6 160

    Tetrahydrofuran 7.2 720

    Tetralin 1.0 100Toluene 8.9 890

    Trichloroethylene 0.8 80

    Xylenes 21.7 2170

  • 7/27/2019 Gas Chromatography -2 OVI

    20/32

    7/24/2013 UNICHEM 20

    Options for Determining Levels of Class 2Residual Solvents in Drug Products

    Option 1:

    All the components of the drug product (drug substancesand excipients) meet the concentration limits (ppm)listed in Table 2, and the daily dose does not exceed 10g: drug product passes.

    Option 2:

    At least one of the components of the drug productexceeds the concentration limits (ppm), or the dailydose exceeds 10 g: the daily exposure to a solvent

    (calculated as the sum of the components contributions)should be less than the PDE (mg).

  • 7/27/2019 Gas Chromatography -2 OVI

    21/32

    7/24/2013 UNICHEM 21

    Example 1: Option 1 and Option 2,with acetonitrile

    PDE acetonitrile = 4.1 mg/day, thus Option 1limit is 410 ppm

    (from Table 2). 5.0 g drug product/day. Composed of two excipients

    Excipients 1 meets Option 1limit of 410 ppm. Drug substance, excipients 2, and drug product do not meet

    Option 1limit of 410 ppm. Drug product however, does meet Option 2limit of 4.1 mg/day.

    Component Amount inFormulation

    (g)

    AcetonitrileContent-Limit

    (ppm)

    Daily Exposure

    (mg)

    Drug Substance 0.3 800 (exceeds) 0.24

    Excipient 1 0.9 400 (pass) 0.36

    Excipient 2 3.8 800 (exceeds) 3.04

    Drug Product

    Calculated data*

    5.0 728 (exceeds)* 3.64 (PASS)*

    E l 2 O ti 1 d O ti 2 ith

  • 7/27/2019 Gas Chromatography -2 OVI

    22/32

    7/24/2013 UNICHEM 22

    Example 2: Option 1 and Option 2, withacetonitrile

    PDE acetonitrile = 4.1 mg/day, thus Option 1limit is 410 ppm

    (from Table 2). 5.0 g drug product/day. Composed of two excipients

    Drug product does not meet Option 1limit (410 ppm) or Option 2limit (4.1mg/day).

    Manufacturer could test to see if manufacturing reduced the level ofacetonitrile in the drug product below 410 ppm; if so it passes.

    Component Amount inFormulation

    (g)

    Acetonitrile Content-Limit

    (ppm)

    Daily Exposure

    (mg)

    Drug Substance 0.3 800 (exceeds) 0.24

    Excipient 1 0.9 2000 (exceeds) 1.80

    Excipient 2 3.8 800 (exceeds) 3.04

    Drug Product

    Calculated data*

    5.0 1016 (exceeds)* 5.08 (FAIL)*

  • 7/27/2019 Gas Chromatography -2 OVI

    23/32

    7/24/2013 UNICHEM 23

    Limits of Residual Solvents: Class 3

    Class 3: 27 solvents

    Less toxic and of lower risk to human health Unless otherwise stated in the individual

    monograph, PDE is NMT 50 mg/day,corresponding to a concentration limit of 5000

    ppm for daily doses not greater than 10 g ofproduct.

    Use Loss on Drying in NMT 0.5%.

    If the monograph allows for a concentration

    resulting in more than 50 mg/day, Class 3solvents must be identified and quantified.

  • 7/27/2019 Gas Chromatography -2 OVI

    24/32

    7/24/2013 UNICHEM 24

    Table 3. Class 3 Residual Solvents

    Acetic acid Heptane

    Acetone Isobutyl acetateAnisole Isopropyl acetate

    1-Butanol Methyl acetate

    2-Butanol 3-Methyl-1-butanol

    Butyl acetate Methylethylketone

    tert-Butylmethyl ether Methylisobutylketone

    Cumene 2-Methyl-l-propanol

    Dimethyl sulfoxide Pentane

    Ethanol 1-Pentanol

    Ethyl acetate 1-Propanol

    Ethyl ether 2-Propanol

    Ethyl formate Propyl acetate

    Formic acid

    O h id l l

  • 7/27/2019 Gas Chromatography -2 OVI

    25/32

    7/24/2013 UNICHEM 25

    Other Residual solvents No adequate toxicological data on which to base a PDE

    was found.

    Residual levels of these solvents in drug products shallbe justified.

    Table 4.Other Residual Solvents1,1-Diethoxypropane Methyl isopropyl ketone

    1,1-Dimethoxypropane Methytetrahydrofuran

    2,2-Dimethoxypropane Petroleum ether

    Isooctane Trichloroacetic acid

    Isopropyl ether Trifluroacetic acid

  • 7/27/2019 Gas Chromatography -2 OVI

    26/32

    7/24/2013 UNICHEM 26

    Analytical Procedures (ICH, EP)

    ICH:Any harmonized procedures for

    determining levels of residual solvents asdescribed in the pharmacopoeias should beused, if feasible. Otherwise, manufacturerswould be free to select the most appropriate

    validated analytical procedure . . . EP:. . . The methodology in the general

    analytical method (2.2.24)is to be appliedwherever possible. Otherwise an appropriate

    validated method is to be employed.

  • 7/27/2019 Gas Chromatography -2 OVI

    27/32

    7/24/2013 UNICHEM 27

    Analytical Procedures USP

    USP:. . . The procedures described in . . . Thisgeneral chapter are to be applied wheneverpossible. Otherwise manufacturers mayselect the most appropriate validatedanalytical procedure for a particularapplication . . .

    Id tifi ti C t l d

  • 7/27/2019 Gas Chromatography -2 OVI

    28/32

    7/24/2013 UNICHEM 28

    Identification, Control, andQuantification of Residual Solvents

    Class 1 and Class 2 Residual Solvents Procedure A-Identification and Limit Test

    Procedure B-Confirmatory Test

    Procedure C-Quantitative Test

    Class 3 Residual Solvents LOD, followed if necessary by Gas

    Chromatography analysis if it exceeds0.5%.

    Manufacturers statement regarding

  • 7/27/2019 Gas Chromatography -2 OVI

    29/32

    7/24/2013 UNICHEM 29

    Manufacturers statement regardingResidual solvents

    Statement/Declaration shall include-

    All Class 1 solvents used or generated

    All Class 2 solvents "likely to be present

    Whether Class 3 solvents are" likely to be present" andidentity of all Class 3 solvents present at greater than 0.5%

    All other solvents "likely to be present, as applicable.

    The expected control limits for the solvents identifiedabove

    C l l i f S d d i

  • 7/27/2019 Gas Chromatography -2 OVI

    30/32

    7/24/2013 UNICHEM 30

    Calculation of Standard concentrationSample containing Methanol as a residual solvent

    Limit as per ICH: 3000 ppm

    Sample concentration: 500 mg of sample in 5 mL of DMF(diluent)

    Factor is (5ml / 0.5g) = 10

    Standard concentration:

    Absolute concentration = ICH limit / Factori.e. 3000 / 10 = 300 ppm

  • 7/27/2019 Gas Chromatography -2 OVI

    31/32

    7/24/2013 UNICHEM 31

    Calculation of residual solvent

    Standard preparation: 30mg of Methanol to 100mL with

    DMF

    Calculations: Methanol content in ppm

    Area in sample Wt of Std (g) 5---------------------- X -------------- X --------------- X 106

    Area in std 100 Wt of spl (g)

  • 7/27/2019 Gas Chromatography -2 OVI

    32/32

    7/24/2013 UNICHEM 32

    Thank You !

    Any Questions ?